rct
    2024

    A randomized, double-blind, placebo-controlled study to evaluate the benefits of a standardized Nigella sativa oil containing 5% thymoquinone in reducing the symptoms of seasonal allergy

    Majeed A, Majeed S, Parameswarappa AK, Murali A, Gudimallam S

    Published in Medicine

    Methodology

    Randomized, double-blind, placebo-controlled trial of Nigella sativa oil 250 mg with piperine twice daily for 15 days in allergic rhinitis.

    Key Findings

    Significant reduction in Total Nasal Symptom Score and Total Ocular Symptoms Score versus placebo over 15 days.

    Conclusions

    Standardized Nigella sativa oil reduced seasonal allergy symptoms over a short intervention.

    Limitations

    Very short 15-day duration, small sample, manufacturer-affiliated authors, combination product with piperine.

    Supplements Studied

    A significant reduction in Total Nasal Symptom Score and Total Ocular Symptoms Score was observed in the NSO group compared to the placebo

    Related Health Concerns

    Study Details

    Year:2024
    Sample Size:65
    Duration:2 weeks
    Quality Score:5/10

    Disclosures

    Funding

    Manufacturer-affiliated authors (Sami-Sabinsa Group)

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.